<DOC>
	<DOCNO>NCT02528318</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability lucinactant inhalation , administer aerosolize dose four escalate dos preterm neonates 26 28 week gestational age receive nasal continuous positive airway pressure ( nCPAP ) respiratory distress syndrome ( RDS ) compare neonate receive nCPAP alone .</brief_summary>
	<brief_title>Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 28 Weeks PMA</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>1 . Informed consent legally authorize representative . 2 . Gestational age 26 28 complete week post menstrual age ( PMA ) . 3 . Successful implementation control nCPAP within 90 minute birth . 4 . Spontaneous breathing . 5 . Chest radiograph consistent RDS . 6 . Within first 20 hour birth , require nCPAP 5 6 cm H2O 0.25 0.50 clinically indicate least 30 minute . Transient ( &lt; 10 minute ) FiO2 excursions 0.25 0.50 reset 30 minute requirement . 1 . Heart rate stabilize 100 beats/minute within 5 minute birth . 2 . Recurrent episodes apnea occur initial newborn resuscitation period ( ie , 10 minute birth ) require intermittent positive pressure breath use inflate pressure set CPAP pressure administer manually mechanically patient interface . 3 . A 5 minute Apgar score &lt; 5 . 4 . Major congenital malformation ( ) cranial/facial abnormality preclude nCPAP , diagnose antenatally immediately birth . 5 . Other disease condition potentially interfere cardiopulmonary function ( eg , hydrops fetalis congenital infection TORCH ) . 6 . Known suspected chromosomal abnormality syndrome . 7 . Prolong rupture membrane ( PROM ) &gt; 2 week . 8 . Evidence hemodynamic instability require vasopressor steroid hemodynamic support and/or presume clinical sepsis . 9 . Need endotracheal intubation mechanical ventilation . 10 . Has administer : another investigational agent investigational medical device , surfactant agent , steroid treatment birth .</criteria>
	<gender>All</gender>
	<minimum_age>26 Weeks</minimum_age>
	<maximum_age>28 Weeks</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>